Search
Now showing items 1-10 of 10
Measuring the outcomes of a comprehensive HIV care course: pilot test at the Infectious Diseases Institute, Kampala, Uganda
(Lippincott Williams & Wilkins, 2006)
Objective: To evaluate the effects of the Infectious Diseases Institute’s 4-week course for African doctors on comprehensive management of HIV including antiretroviral therapy on four outcomes: (1) clinical skills, (2) ...
Pattern of neuropsychological performance among HIV positive patients in Uganda
(BioMed Central, 2007)
Background: Few studies have examined cognitive functioning of HIV positive patients in sub-Saharan Africa. It cannot be assumed that HIV positive patients in Africa exhibit the same declines as patients in high-resource ...
Laboratory medicine in Africa: a barrier to effective health care
(University of Chicago Press, 2006)
Providing health care in sub-Saharan Africa is a complex problem. Recent reports call for more resources to assist in the prevention and treatment of infectious diseases that affect this population, but policy makers, ...
Rifampicin for continuation phase tuberculosis treatment in Uganda: a cost-effectiveness analysis
(Public Library of Science, 2012-06)
Background: In Uganda, isoniazid plus ethambutol is used for 6 months (6HE) during the continuation treatment phase of new tuberculosis (TB) cases. However, the World Health Organization (WHO) recommends using isoniazid ...
Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy
(CID, 2008)
Background. Cryptococcal meningitis (CM) is the proximate cause of death in 20%–30% of persons with acquired immunodeficiency syndrome in Africa. Methods. Two prospective, observational cohorts enrolled human immunodeficiency ...
Etiology of pruritic papular eruption with HIV infection in Uganda
(American Medical Association., 200-12-01)
Context A frequent cause of human immunodeficiency virus (HIV)–related morbidity in sub-Saharan Africa is a commonly occurring, intensely pruritic skin rash. The resulting scars are disfiguring and stigmatizing. Despite ...
Adherence to anti-retroviral ttherapy among HIV infected mothers on option B plus aattending the Upper Mulago post natal clinic
(Makerere University, 2014-06)
Background: Over 90% of the children living with HIV in Sub-Saharan Africa acquire the infection through mother-to-child transmission (MTCT). Elimination of MTCT (eMTCT) of HIV could be realized by country wide rollout of ...
Modern contraceptive uptake and associated factors among hiv positive women attending Soroti Hospital, Uganda
(Makerere University, 2015-07)
Introduction: In SSA about 60% of PHAs are reproductive age women. HIV+ women continue to have unplanned pregnancies due to low uptake of MFP methods. Unplanned pregnancies among PHAs are associated with increased paediatric ...
Barriers and facilitators to chemotherapy initiation and adherence for patients with HIV-associated Kaposi’s sarcoma in Kenya: A qualitative study
(BMC, 2022)
Background: Kaposi sarcoma is one of the most prevalent HIV‑associated malignancies in sub‑Saharan Africa and is often diagnosed at advanced stage of disease. Only 50% of KS patients who qualify for chemotherapy receive ...
Understanding diagnostic delays for kaposi sarcoma in Kenya: A qualitative study
(2022)
Background: Although HIV-associated Kaposi sarcoma (KS) is frequently diagnosed at an advanced stage in sub-Saharan Africa, reasons for diagnostic delays have not been well described. Methods: We enrolled patients >18 years ...